Differential metabolism of benzo[α]pyrene in vitro by human placental tissues exposed to active maternal cigarette smoke

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 80, Issue 1, 2007, Pages 49-56

  Sanyal, Mrinal K ^a,b   Li, You Lan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Benzo pyrene metabolism; Cigarette smoke exposure; DNA adduct production; Human pregnancy and placenta; Inter individual variations

Indexed keywords

BENZO[A]PYRENE; CIGARETTE SMOKE;

AQUEOUS SOLUTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DNA ADDUCT; ENVIRONMENTAL EXPOSURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOTHER; PLACENTA; PRENATAL EXPOSURE; PRIORITY JOURNAL; SELF REPORT; TISSUE METABOLISM; TROPHOBLAST; XENOBIOTIC METABOLISM;

BENZO(A)PYRENE; BENZOPYRENE HYDROXYLASE; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSOMES; PLACENTA; PREGNANCY; SMOKING;

NICOTIANA TABACUM;

EID: 33847176929     PISSN: 15429733     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrb.20102     Document Type: Article

References (30)

1. Andres RL, Day MC. 2000. Perinatal complications associated with maternal tobacco use. Semin Neonatol 5:231-241.
2. Autrup H, Vestergaard AB. 1996. Transplacental transfer of environmental genotoxins-polycyclic aromatic hydrocarbon-albumins in non-smoking women. Environ Health Perspect 104(Suppl):625-627.
3. Boysen G, Hecht SS. 2003. Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat Res 543:17-30.
4. Everson RB, Randerath E, Santella RM, Avitts TA, Weinstein IB, Randerath K. 1988. Quantitative association between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst 80:567-576.
5. Fujino T, Gottlieb K, Manchester DK, Park SS, West D, Gurtoo HL, Tarone RE, Gelboin HV. 1984. Monoclonal antibody phenotyping of interindividual differences in cytochrome P 450 dependent reactions of single and twin placentas. Cancer Res 44:3916-3923.
6. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. 2004. Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol 5: 763-769.
7. Gladden BC, Zadorozhnaja TD, Chislovska N, Hryhorczuk DC, Kennicutt MC 2nd, Little RE. 2000. Polycyclic aromatic hydrocarbons in placenta. Hum Exp Toxicol 19:597-603.
8. Gurtoo HL, Williams CJ, Gottlieb K, Mulhern Al, Caballes L, Vaught JB, Marinella AJ, Bansal SK. 1983. Population distribution of placental benzo[a]pyrene metabolism in smokers. Int J Cancer 31:29-37.
9. Henningfield JE, Benowitz NL. 2004. Pharmacology of nicotine addiction. In: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W, editors. Tobacco and public health: science and policy. New York: Oxford University Press. p 129.
10. Hu W, Feng Z, Tang MS. 2003. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms. Biochemistry 42:10012-10023.
11. Ichiba M, Hagmar L, Rannug A, Hogstedt B, Alexandrie AK, Carstensen U, Hemminki K. 1994. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15:1347-1352.
12. Jiang G, Jankowiak R, Grubor N, Banasiewicz M, Small GJ, Skorvaga M, Van Houten B, States JC. 2004. Supercoiled DNA promotes formation of intercalated cis-N2-deoxyguanine adducts and base-stacked trans-N2-deoxyguanine adducts by (+)-7R,8S-dihydrodiol-9S,10R-epoxy-7,8,9,10-tetra- hydrobenzo[a]pyrene. Chem Res Toxicol 17:330-339.
13. Kadlubar FF, Hammons GJ. 1987. The role of cytochrome P 450 in the metabolism of chemical carcinogens. In: Guengerich FP, editor. Mammalian cytochrome P-450. Vol. 2. Boca Raton: CRC Press. p 81-130.
14. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. 1990. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 263: 131-133.
15. Li D, Firozi PF, Wang LE, Bosken CH, Spitz MR, Hong WK, Wei Q. 2001. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis. Cancer Res 61: 1445-1450.
16. Lieberman E, Gremy I, Lang JM, Cohen AP. 1994. Low birth weight at term and timing of fetal exposure to maternal smoking. Am J Public Health 84:1127-1131.
17. Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P. 2004. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH. Cancer Epidemiol Biomarkers Prev 13:1342-1348.
18. Manchester DK, Weston A, Choi JS, Trivers G, Fennessey PV, Quintana E, Farmer PB, Mann DL, Harris CC. 1988. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci USA 85:9243-9247.
19. Miller MS. 2004. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. Toxicol Appl Pharmacol 198:95-110.
20. Nebert DW, Puga A, Vasiliou V. 1993. Role of Ah receptor and the dioxin-inducible (Ah) gene battery in toxicity, cancer and signal transduction. Ann NY Acad Sci 685:624-640.
21. Pasanen M, Pelkonen O. 1994. The expression and environmental regulation of P450 enzymes in human placenta. Crit Rev Toxicol 24: 211-229.
22. Perera FP, Tang D, Tu YH, Cruz LA, Borjas M, Bernert T, Whyatt RM. 2004a. Bio-markers in maternal and newborn blood indicate heightened fetal susceptibility to pro-carcinogenic DNA damage. Environ Health Perspect 112:1133-1136.
23. Perera FP, Rauh V, Whyatt RM, Tsai WY, Bernert JT, Tu YH, Andrews H, Ramirez J, Qu L, Tang D. 2004b. Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect 12:626-630.
24. Rebbeck TR, Spitz M, Wei X. 2004. Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5: 589-597.
25. Sanyal MK, Li YL, Biggers WJ, Satish J, Barnea ER. 1993. Augmentation of polynuclear aromatic hydrocarbon metabolism of human placental tissues of first trimester pregnancy by cigarette smoke exposure. Am J Obstet Gynecol 168:1587-1597.
26. Sanyal MK, Li YL, Belanger K. 1994. Metabolism of polynuclear aromatic hydrocarbon in human placenta influenced by cigarette smoke exposure. Reprod Toxicol 8:411-418.
27. Uzeil M, Griffin GD, Walsh PJ. 1985. Aryl hydrocarbon hydroxylase tissue-specific activities: evidence for baseline levels in mammalian tissues. J Toxicol Environ Health 16:727-732.
28. Werler MM. 1997. Teratogen update: smoking and reproductive outcome. Teratology 55:382-388.
29. Whyatt RM, Bell DA, Jedrychowski W, Santella RM, Garte SJ, Cosma G, Manchester DK, Young TL, Cooper TB, Ottman R, Parerra F. 1998. Polycyclic aromatic hydrocarbon adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19: 1389-1392.
30. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. 2005. The adverse effects of maternal smoking on the human placenta: a review. Placenta 26(Suppl):S81-S86.